SCHEMBL6328348

SCHEMBL6328348

NCC(O)CNc1n[nH]c(=O)c2ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 1/20 0.48
KDM4E B2RXH2 2/20 0.47
AURKB Q96GD4 5/20 0.44
AURKA O14965 1/20 0.43
KMT2A Q03164 3/20 0.42
HIF1A Q16665 1/20 0.42
HTT P42858 3/20 0.42
ALDH1A1 P00352 2/20 0.42
MEN1 O00255 2/20 0.42
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42
THRB P10828 1/20 0.42
RECQL P46063 1/20 0.42
BLM P54132 1/20 0.42
LMNA P02545 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CYP1A2 P05177 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
POLB P06746 1/20 0.40
ATM Q13315 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6327167 0.75 PRMT5 (0.51) PRMT5KDM4EAURKBAURKAKMT2A
SCHEMBL6326992 0.74 PRMT5 (0.50) PRMT5KDM4EAURKBAURKAKMT2A
SCHEMBL6332305 0.74 AURKB (0.38) KDM4EAURKBAURKAKMT2AHIF1A
SCHEMBL6325736 0.72 PRMT5 (0.48) PRMT5KDM4EAURKBAURKAKMT2A
SCHEMBL6334502 0.71 ELANE (0.54) PRMT5KDM4EAURKBAURKAKMT2A
SCHEMBL28658822 0.69 AURKB (0.63) PRMT5KDM4EAURKBCYP1A2
SCHEMBL2511703 0.66 AURKB (0.59) PRMT5KDM4EAURKBAURKAMAPT
SCHEMBL21405619 0.66 ROCK1 (0.54) KDM4EATMNPSR1MAPK1
SCHEMBL6448206 0.66 AURKB (0.48) KDM4EAURKBKMT2AHTTALDH1A1
SCHEMBL9584160 0.66 AURKB (0.51) PRMT5KDM4EAURKBAURKAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1423120-A4 2H-PHTHALAZIN-1-ONES AND METHODS FOR USE THEREOF ICOS CORP (US) 2005-12-28 EP disclosed
US-6924284-B2 PARP inhibitors ICOS CORPORATION (US) 2005-08-02 US disclosed
EP-1423120-A1 2H-PHTHALAZIN-1-ONES AND METHODS FOR USE THEREOF ICOS CORPORATION (US) 2004-06-02 EP disclosed
US-20040087588-A1 Parp inhibitors ICOS CORPORATION 2004-05-06 US disclosed
WO-2003015785-A1 2H-PHTHALAZIN-1-ONES AND METHODS FOR USE THEREOF ICOS CORPORATION (US) 2003-02-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040087588-A1 Parp inhibitors PARP1, PARP2, PARP11 PRMT5 1011/4885KDM4E 360/4885AURKB 57/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.